In terms of AGTR1 polymorphism, AC + CC genotype significantly increased the control rate of hypertension in patients with valsartan treatment compared to the AA genotype (AC + CC vs. AA: OR 2.988, 95% CI 1.340–6.661, P = 0.007). This evidence concerns the gene AGTR1 and hypertensive disorder.